PHATHOM PHARMACEUTICALS, INC. (PHAT) Free cash flow 2019–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$167.0MFY2025 · since FY2019: -$36.6M → -$167.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$167.0M | +37.4% |
| FY2024 | -$266.9M | -91.7% |
| FY2023 | -$139.2M | +5.7% |
| FY2022 | -$147.6M | +0.8% |
| FY2021 | -$148.8M | -110.4% |
| FY2020 | -$70.7M | -93.0% |
| FY2019 | -$36.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net incomePHAT Net marginPHAT Gross profitPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →